Opiate users' knowledge about overdose prevention and naloxone in New York City: A focus group study

Harm Reduction Journal

Volumn 3, Issue , 2006, Pages

  Worthington, Nancy ^a   Piper, Tinka Markham ^b   Galea, Sandro ^b,c   Rosenthal, David ^a  

^a Lower East Side Harm Reduction Center   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE;

ARTICLE; ATTITUDE TO HEALTH; DRUG OVERDOSE; DRUG USE; FEAR; FEEDBACK SYSTEM; HEALTH PROGRAM; HUMAN; POLICE; UNITED STATES;

EID: 33748191742     PISSN: 14777517     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-3-19     Document Type: Article

References (30)

1. Drug Abuse Warning Network: Mortality Data from the Drug Abuse Warning Network, 2002. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. [http://dawninfo.samhsa.gov/old_dawn/pubs_94_02/mepubs/files/ DAWN2002/DAWN_A_ME.pdf].
2. Darke S, Ross J, Cohen J, Hall W: Contexts and correlates of non-fatal overdose among heroin users in Sydney. Sydney: University of New South Wales; 1994. (NDARC research monograph No 20)
3. Strang J, Best D, Man L, Noble A, Gossop M: Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. International Journal of Drug Policy 2000, 11:437-445.
4. Davoli M, Perucci CA, Forastiere F, Doyle P, Paiti E, Zaccarelli M, Abeni DD: Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users. Inter J Epidmiol 1993, 22:273-377.
5. Haastrup S, Jepsen PW: Eleven year follow-up of 300 young opiod addicts. Acta Psychiatr Scand 1988, 77:22-26.
6. Tunving K: Fatal outcome in drug addiction. Acta Psychiatr Scand 1988, 77:551-556.
7. Joe GW, Simpson DD: Mortality rates among opiod addicts in a longitudinal study. Am J Public Health 1987, 77:347-348.
8. Vaillant GE: A 20 year follow-up of new york narcotic addicts. Arch Ben Psychiatry 1973, 29:237-241.
9. Oppenheimer E, Tobutt C, Tayolr C, Andrew T: Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994, 89:1299-1308.
10. Darke S, Zador D: Fatal heroin "overdose": a review. Addiction 1996, 91:1765-1772.
11. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine and alcohol combinations in drug overdose deaths in new york city, 1990-1998. Addiction 2003, 98(6):739-747.
12. New York City Department of Health and Mental Hygiene (DOHMH): Summary of vital statistics 2002: the city of new york. [http://www.nyc.gov/html/ doh/downloads/pdf/vs/2002sum.pdf]. New York: Office of Vital Statistics
13. Karpati A, Lu X, Mostashari F, Thorpe L, Frieden TR: The health of central bronx. NYC Community Health Profiles 2003, 1(191-12 [http://www.nyc.gov/html/doh/downloads/pdf/data/2003nhp-bronxa.pdf].
14. Karpati A, Lu X, Mostashari F, Thorpe L, Frieden TR: The health of central bronx. NYC Community Health Profiles 2003, 1(401-12 [http://www.nyc.gov/html/doh/downloads/pdf/data/2003nhp-bronxa.pdf].
15. Zador D, Sunjic S, Darke S: Heroin-related deaths in New South Whales, 1992: toxicological findings and circumstances. Medical Journal Australia 1996, 164:204.
16. Darke S, Hall W: Heroin overdose: research and evidence-based intervention. Journal of Urban Health 2003, 80:189-200.
17. Powis G, Strang J, Griffiths J, Taylor C, Williamson S, Fountain J, Gossop M: Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction 1999, 94:471-478.
18. Sergeev B, Karpets A, Sarang A, Tikhonov M: Prevelance and circumstances of opiate overdose among injection drug users in the Russian Federation. Journal of Public Health 2003, 80:212-219.
19. Chamberlain J, Klein B: A comprehensive review of naloxone for the emergency physician. American Journal of Emergency Medicine 1994, 12:650-660.
20. Goldfrank LR, Hoffman RS: The poisoned patient with altered consciousness. Journal of the American Medical Association 1995, 274:562-569.
21. Burris S, Norland J, Edlin B: Legal Aspects of providing naloxone to heroin users in the United States. International Journal of Drub Policy 2001, 12:237-248.
22. Chicago Recovery Alliance: Opiate OD prevention/intervention work in Chicago. http://www.anypositivechange.org/OD1202.pdf].
23. Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, Welch S, Gossop M: Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction 1999, 94(2):199-205.
24. McGregor C, Darke S, Ali R, Christie P: Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998, 93(5):701-711.
25. Hargreaves K, Lenton S: The naloxone feasibility study. Perth, Western Australia: National Drug and Research Institute, Curtin University of Technology; 2000 in press.
26. Lenton SR, Hargreaves KM: Should we conduct a trail of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J 2000, 173(5):260-263.
27. Darke S: Attacking overdose on the home front. Comments on Strang et al.'s "Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and accessibility." Addiction 1999, 93(2):205-207.
28. Ashworth A, Kidd A: Apparent advantages may be balanced by hidden harms. BMJ 2001, 323:394.
29. Darke S, Hall W: The distribution of naloxone to heroin users. Addiction 1997, 92(9):1195-1199.
30. Vilke GM, Buchanan J, Dunford JV, Chan DC: Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehospital Emergency Care 1999, 3:183-186.